Cargando…
_version_ 1784751739751104512
author Stamberger, Hannah
Crosiers, David
Balagura, Ganna
Bonardi, Claudia M.
Basu, Anna
Cantalupo, Gaetano
Chiesa, Valentina
Christensen, Jakob
Dalla Bernardina, Bernardo
Ellis, Colin A.
Furia, Francesca
Gardiner, Fiona
Giron, Camille
Guerrini, Renzo
Klein, Karl Martin
Korff, Christian
Krijtova, Hana
Leffner, Melanie
Lerche, Holger
Lesca, Gaetan
Lewis-Smith, David
Marini, Carla
Marjanovic, Dragan
Mazzola, Laure
McKeown Ruggiero, Sarah
Mochel, Fanny
Ramond, Francis
Reif, Philipp S.
Richard-Mornas, Aurélie
Rosenow, Felix
Schropp, Christian
Thomas, Rhys H.
Vignoli, Aglaia
Weber, Yvonne
Palmer, Elizabeth
Helbig, Ingo
Scheffer, Ingrid E.
Striano, Pasquale
Møller, Rikke S.
Gardella, Elena
Weckhuysen, Sarah
author_facet Stamberger, Hannah
Crosiers, David
Balagura, Ganna
Bonardi, Claudia M.
Basu, Anna
Cantalupo, Gaetano
Chiesa, Valentina
Christensen, Jakob
Dalla Bernardina, Bernardo
Ellis, Colin A.
Furia, Francesca
Gardiner, Fiona
Giron, Camille
Guerrini, Renzo
Klein, Karl Martin
Korff, Christian
Krijtova, Hana
Leffner, Melanie
Lerche, Holger
Lesca, Gaetan
Lewis-Smith, David
Marini, Carla
Marjanovic, Dragan
Mazzola, Laure
McKeown Ruggiero, Sarah
Mochel, Fanny
Ramond, Francis
Reif, Philipp S.
Richard-Mornas, Aurélie
Rosenow, Felix
Schropp, Christian
Thomas, Rhys H.
Vignoli, Aglaia
Weber, Yvonne
Palmer, Elizabeth
Helbig, Ingo
Scheffer, Ingrid E.
Striano, Pasquale
Møller, Rikke S.
Gardella, Elena
Weckhuysen, Sarah
author_sort Stamberger, Hannah
collection PubMed
description BACKGROUND AND OBJECTIVES: Pathogenic STXBP1 variants cause a severe early-onset developmental and epileptic encephalopathy (STXBP1-DEE). We aimed to investigate the natural history of STXBP1-DEE in adults focusing on seizure evolution, the presence of movement disorders, and the level of functional (in)dependence. METHODS: In this observational study, patients with a minimum age of 18 years carrying a (likely) pathogenic STXBP1 variant were recruited through medical genetics departments and epilepsy centers. Treating clinicians completed clinical questionnaires and performed semistructured video examinations while performing tasks from the (modified) Unified Parkinson Disease Rating Scale when possible. RESULTS: Thirty adult patients were included for summary statistics, with video recordings available for 19 patients. The median age at last follow-up was 24 years (range 18–58 years). All patients had epilepsy, with a median onset age of 3.5 months. At last follow-up, 80% of adults had treatment-resistant seizures despite long periods of seizure freedom in 37%. Tonic-clonic, focal, and tonic seizures were most frequent in adults. Epileptic spasms, an unusual feature beyond infancy, were present in 3 adults. All individuals had developmental impairment. Periods of regression were present in 59% and did not always correlate with flare-ups in seizure activity. Eighty-seven percent had severe or profound intellectual disability, 42% had autistic features, and 65% had significant behavioral problems. Video examinations showed gait disorders in all 12 patients able to walk, including postural abnormalities with external rotation of the feet, broad-based gait, and asymmetric posture/dystonia. Tremor, present in 56%, was predominantly of the intention/action type. Stereotypies were seen in 63%. Functional outcome concerning mobility was variable ranging from independent walking (50%) to wheelchair dependence (39%). Seventy-one percent of adults were nonverbal, and all were dependent on caregivers for most activities of daily living. DISCUSSION: STXBP1-DEE warrants continuous monitoring for seizures in adult life. Periods of regression are more frequent than previously established and can occur into adulthood. Movement disorders are often present and involve multiple systems. Although functional mobility is variable in adulthood, STXBP1-DEE frequently leads to severe cognitive impairments and a high level of functional dependence. Understanding the natural history of STXBP1-DEE is important for prognostication and will inform future therapeutic trials.
format Online
Article
Text
id pubmed-9302932
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93029322022-08-01 Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood Stamberger, Hannah Crosiers, David Balagura, Ganna Bonardi, Claudia M. Basu, Anna Cantalupo, Gaetano Chiesa, Valentina Christensen, Jakob Dalla Bernardina, Bernardo Ellis, Colin A. Furia, Francesca Gardiner, Fiona Giron, Camille Guerrini, Renzo Klein, Karl Martin Korff, Christian Krijtova, Hana Leffner, Melanie Lerche, Holger Lesca, Gaetan Lewis-Smith, David Marini, Carla Marjanovic, Dragan Mazzola, Laure McKeown Ruggiero, Sarah Mochel, Fanny Ramond, Francis Reif, Philipp S. Richard-Mornas, Aurélie Rosenow, Felix Schropp, Christian Thomas, Rhys H. Vignoli, Aglaia Weber, Yvonne Palmer, Elizabeth Helbig, Ingo Scheffer, Ingrid E. Striano, Pasquale Møller, Rikke S. Gardella, Elena Weckhuysen, Sarah Neurology Research Article BACKGROUND AND OBJECTIVES: Pathogenic STXBP1 variants cause a severe early-onset developmental and epileptic encephalopathy (STXBP1-DEE). We aimed to investigate the natural history of STXBP1-DEE in adults focusing on seizure evolution, the presence of movement disorders, and the level of functional (in)dependence. METHODS: In this observational study, patients with a minimum age of 18 years carrying a (likely) pathogenic STXBP1 variant were recruited through medical genetics departments and epilepsy centers. Treating clinicians completed clinical questionnaires and performed semistructured video examinations while performing tasks from the (modified) Unified Parkinson Disease Rating Scale when possible. RESULTS: Thirty adult patients were included for summary statistics, with video recordings available for 19 patients. The median age at last follow-up was 24 years (range 18–58 years). All patients had epilepsy, with a median onset age of 3.5 months. At last follow-up, 80% of adults had treatment-resistant seizures despite long periods of seizure freedom in 37%. Tonic-clonic, focal, and tonic seizures were most frequent in adults. Epileptic spasms, an unusual feature beyond infancy, were present in 3 adults. All individuals had developmental impairment. Periods of regression were present in 59% and did not always correlate with flare-ups in seizure activity. Eighty-seven percent had severe or profound intellectual disability, 42% had autistic features, and 65% had significant behavioral problems. Video examinations showed gait disorders in all 12 patients able to walk, including postural abnormalities with external rotation of the feet, broad-based gait, and asymmetric posture/dystonia. Tremor, present in 56%, was predominantly of the intention/action type. Stereotypies were seen in 63%. Functional outcome concerning mobility was variable ranging from independent walking (50%) to wheelchair dependence (39%). Seventy-one percent of adults were nonverbal, and all were dependent on caregivers for most activities of daily living. DISCUSSION: STXBP1-DEE warrants continuous monitoring for seizures in adult life. Periods of regression are more frequent than previously established and can occur into adulthood. Movement disorders are often present and involve multiple systems. Although functional mobility is variable in adulthood, STXBP1-DEE frequently leads to severe cognitive impairments and a high level of functional dependence. Understanding the natural history of STXBP1-DEE is important for prognostication and will inform future therapeutic trials. Lippincott Williams & Wilkins 2022-07-19 /pmc/articles/PMC9302932/ /pubmed/35851549 http://dx.doi.org/10.1212/WNL.0000000000200715 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Stamberger, Hannah
Crosiers, David
Balagura, Ganna
Bonardi, Claudia M.
Basu, Anna
Cantalupo, Gaetano
Chiesa, Valentina
Christensen, Jakob
Dalla Bernardina, Bernardo
Ellis, Colin A.
Furia, Francesca
Gardiner, Fiona
Giron, Camille
Guerrini, Renzo
Klein, Karl Martin
Korff, Christian
Krijtova, Hana
Leffner, Melanie
Lerche, Holger
Lesca, Gaetan
Lewis-Smith, David
Marini, Carla
Marjanovic, Dragan
Mazzola, Laure
McKeown Ruggiero, Sarah
Mochel, Fanny
Ramond, Francis
Reif, Philipp S.
Richard-Mornas, Aurélie
Rosenow, Felix
Schropp, Christian
Thomas, Rhys H.
Vignoli, Aglaia
Weber, Yvonne
Palmer, Elizabeth
Helbig, Ingo
Scheffer, Ingrid E.
Striano, Pasquale
Møller, Rikke S.
Gardella, Elena
Weckhuysen, Sarah
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
title Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
title_full Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
title_fullStr Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
title_full_unstemmed Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
title_short Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
title_sort natural history study of stxbp1-developmental and epileptic encephalopathy into adulthood
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302932/
https://www.ncbi.nlm.nih.gov/pubmed/35851549
http://dx.doi.org/10.1212/WNL.0000000000200715
work_keys_str_mv AT stambergerhannah naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT crosiersdavid naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT balaguraganna naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT bonardiclaudiam naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT basuanna naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT cantalupogaetano naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT chiesavalentina naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT christensenjakob naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT dallabernardinabernardo naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT elliscolina naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT furiafrancesca naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT gardinerfiona naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT gironcamille naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT guerrinirenzo naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT kleinkarlmartin naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT korffchristian naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT krijtovahana naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT leffnermelanie naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT lercheholger naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT lescagaetan naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT lewissmithdavid naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT marinicarla naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT marjanovicdragan naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT mazzolalaure naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT mckeownruggierosarah naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT mochelfanny naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT ramondfrancis naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT reifphilipps naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT richardmornasaurelie naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT rosenowfelix naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT schroppchristian naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT thomasrhysh naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT vignoliaglaia naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT weberyvonne naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT palmerelizabeth naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT helbigingo naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT schefferingride naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT strianopasquale naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT møllerrikkes naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT gardellaelena naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood
AT weckhuysensarah naturalhistorystudyofstxbp1developmentalandepilepticencephalopathyintoadulthood